Literature DB >> 4800749

Protein binding of drugs in plasma from patients with acute renal failure.

F Andreasen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4800749     DOI： 10.1111/j.1600-0773.1973.tb01488.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  31 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

3.  Plasma protein binding of phenylbutazone during recovery from acute renal failure.

Authors:  M M Mussche; F M Belpaire; M G Bogaert
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

4.  Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells.

Authors:  G M Rocha; L F Michea; E M Peters; M Kirby; Y Xu; D R Ferguson; M B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.

Authors:  A Viani; G Rizzo; M Carrai; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

6.  Decreased drug binding in serum from patients with chronic hepatic disease.

Authors:  S Wallace; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

7.  Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.

Authors:  F Andreasen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

8.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

9.  Plasma protein binding of azapropazone in patients with kidney and liver disease.

Authors:  E Jähnchen; K J Blanck; K H Breuing; H J Gilfrich; T Meinertz; D Trenk
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.